Anticoagulant Market 2028 By Drug Class, Route of Administration, Application | The Insight Partners

Anticoagulant Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (NOACs, Heparin and LMWH, Vitamin K Antagonist, Others); Route of Administration (Oral Anticoagulant, Injectable Anticoagulant); Application (Atrial Fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Others)

Report Code: TIPRE00020940 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Anticoagulant drugs or blood thinners drugs are chemical substances that helps to extend time for blood clotting and reduce blood coagulation. These drugs are majorly used where high risk of blood clots probability is high, in medical conditions, such as deep vein thrombosis, atrial fibrillation, stroke, myocardial infarction, pulmonary embolism, and others.

MARKET DYNAMICS

Increasing prevalence of venous thromboembolism (VTE) and cardiovascular disorders and growing acceptance of novel oral anticoagulants (NOACs) drugs are the major factors for market growth. Moreover, in developing region the rising awareness of novel oral anticoagulants (NOACs) will positively influence market growth.

MARKET SCOPE

The "Anticoagulant Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of anticoagulant market with detailed market segmentation by drug class, route of administration, and application. The anticoagulant market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anticoagulant market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anticoagulant market is segmented on the basis of drug class, route of administration, and application. Based on drug class, the market is segmented as NOACs, heparin and LMWH, vitamin K antagonist, and others. Based on route of administration, the market is segmented as oral anticoagulant and injectable anticoagulant. By application, the market is segmented as atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anticoagulant market based onvarious segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anticoagulant market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anticoagulant market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anticoagulant market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the anticoagulant market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anticoagulant market are anticipated to have lucrative growth opportunities in the future with the rising demand for anticoagulant in the global market. Below mentioned is the list of few companies engaged in the anticoagulant market.

The report also includes the profiles of key players in anticoagulant market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and drug class, route of administration, and application s offered, financial information of last 3 years, key development in past five years.

  •   ASPEN HOLDINGS
  •   BAYER AG
  •   BOEHRINGER INGELHEIM GMBH
  •   BRISTOL-MYERS SQUIBB COMPANY
  •   DAIICHI SANKYO COMPANY LIMITED
  •   GLAXOSMITHKLINE PLC.
  •   JOHNSON AND JOHNSON
  •   PFIZER, INC.
  •   PORTOLA PHARMACEUTICALS, INC.
  •   SANOFI S.A.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anticoagulant Market - By Drug Class
1.3.2 Anticoagulant Market - By Route of Administration
1.3.3 Anticoagulant Market - By Application
1.3.4 Anticoagulant Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTICOAGULANT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTICOAGULANT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTICOAGULANT MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTICOAGULANT - GLOBAL MARKET OVERVIEW
6.2. ANTICOAGULANT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTICOAGULANT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NOACS
7.3.1. Overview
7.3.2. NOACs Market Forecast and Analysis
7.4. HEPARIN AND LMWH
7.4.1. Overview
7.4.2. Heparin and LMWH Market Forecast and Analysis
7.5. VITAMIN K ANTAGONIST
7.5.1. Overview
7.5.2. Vitamin K Antagonist Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTICOAGULANT MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL ANTICOAGULANT
8.3.1. Overview
8.3.2. Oral Anticoagulant Market Forecast and Analysis
8.4. INJECTABLE ANTICOAGULANT
8.4.1. Overview
8.4.2. Injectable Anticoagulant Market Forecast and Analysis
9. ANTICOAGULANT MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ATRIAL FIBRILLATION AND HEART ATTACK
9.3.1. Overview
9.3.2. Atrial Fibrillation and Heart Attack Market Forecast and Analysis
9.4. STROKE
9.4.1. Overview
9.4.2. Stroke Market Forecast and Analysis
9.5. DEEP VEIN THROMBOSIS (DVT)
9.5.1. Overview
9.5.2. Deep Vein Thrombosis (DVT) Market Forecast and Analysis
9.6. PULMONARY EMBOLISM (PE)
9.6.1. Overview
9.6.2. Pulmonary Embolism (PE) Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. ANTICOAGULANT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anticoagulant Market Overview
10.1.2 North America Anticoagulant Market Forecasts and Analysis
10.1.3 North America Anticoagulant Market Forecasts and Analysis - By Drug Class
10.1.4 North America Anticoagulant Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Anticoagulant Market Forecasts and Analysis - By Application
10.1.6 North America Anticoagulant Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anticoagulant Market
10.1.6.1.1 United States Anticoagulant Market by Drug Class
10.1.6.1.2 United States Anticoagulant Market by Route of Administration
10.1.6.1.3 United States Anticoagulant Market by Application
10.1.6.2 Canada Anticoagulant Market
10.1.6.2.1 Canada Anticoagulant Market by Drug Class
10.1.6.2.2 Canada Anticoagulant Market by Route of Administration
10.1.6.2.3 Canada Anticoagulant Market by Application
10.1.6.3 Mexico Anticoagulant Market
10.1.6.3.1 Mexico Anticoagulant Market by Drug Class
10.1.6.3.2 Mexico Anticoagulant Market by Route of Administration
10.1.6.3.3 Mexico Anticoagulant Market by Application
10.2. EUROPE
10.2.1 Europe Anticoagulant Market Overview
10.2.2 Europe Anticoagulant Market Forecasts and Analysis
10.2.3 Europe Anticoagulant Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Anticoagulant Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Anticoagulant Market Forecasts and Analysis - By Application
10.2.6 Europe Anticoagulant Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anticoagulant Market
10.2.6.1.1 Germany Anticoagulant Market by Drug Class
10.2.6.1.2 Germany Anticoagulant Market by Route of Administration
10.2.6.1.3 Germany Anticoagulant Market by Application
10.2.6.2 France Anticoagulant Market
10.2.6.2.1 France Anticoagulant Market by Drug Class
10.2.6.2.2 France Anticoagulant Market by Route of Administration
10.2.6.2.3 France Anticoagulant Market by Application
10.2.6.3 Italy Anticoagulant Market
10.2.6.3.1 Italy Anticoagulant Market by Drug Class
10.2.6.3.2 Italy Anticoagulant Market by Route of Administration
10.2.6.3.3 Italy Anticoagulant Market by Application
10.2.6.4 Spain Anticoagulant Market
10.2.6.4.1 Spain Anticoagulant Market by Drug Class
10.2.6.4.2 Spain Anticoagulant Market by Route of Administration
10.2.6.4.3 Spain Anticoagulant Market by Application
10.2.6.5 United Kingdom Anticoagulant Market
10.2.6.5.1 United Kingdom Anticoagulant Market by Drug Class
10.2.6.5.2 United Kingdom Anticoagulant Market by Route of Administration
10.2.6.5.3 United Kingdom Anticoagulant Market by Application
10.2.6.6 Rest of Europe Anticoagulant Market
10.2.6.6.1 Rest of Europe Anticoagulant Market by Drug Class
10.2.6.6.2 Rest of Europe Anticoagulant Market by Route of Administration
10.2.6.6.3 Rest of Europe Anticoagulant Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anticoagulant Market Overview
10.3.2 Asia-Pacific Anticoagulant Market Forecasts and Analysis
10.3.3 Asia-Pacific Anticoagulant Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Anticoagulant Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Anticoagulant Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Anticoagulant Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anticoagulant Market
10.3.6.1.1 Australia Anticoagulant Market by Drug Class
10.3.6.1.2 Australia Anticoagulant Market by Route of Administration
10.3.6.1.3 Australia Anticoagulant Market by Application
10.3.6.2 China Anticoagulant Market
10.3.6.2.1 China Anticoagulant Market by Drug Class
10.3.6.2.2 China Anticoagulant Market by Route of Administration
10.3.6.2.3 China Anticoagulant Market by Application
10.3.6.3 India Anticoagulant Market
10.3.6.3.1 India Anticoagulant Market by Drug Class
10.3.6.3.2 India Anticoagulant Market by Route of Administration
10.3.6.3.3 India Anticoagulant Market by Application
10.3.6.4 Japan Anticoagulant Market
10.3.6.4.1 Japan Anticoagulant Market by Drug Class
10.3.6.4.2 Japan Anticoagulant Market by Route of Administration
10.3.6.4.3 Japan Anticoagulant Market by Application
10.3.6.5 South Korea Anticoagulant Market
10.3.6.5.1 South Korea Anticoagulant Market by Drug Class
10.3.6.5.2 South Korea Anticoagulant Market by Route of Administration
10.3.6.5.3 South Korea Anticoagulant Market by Application
10.3.6.6 Rest of Asia-Pacific Anticoagulant Market
10.3.6.6.1 Rest of Asia-Pacific Anticoagulant Market by Drug Class
10.3.6.6.2 Rest of Asia-Pacific Anticoagulant Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Anticoagulant Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anticoagulant Market Overview
10.4.2 Middle East and Africa Anticoagulant Market Forecasts and Analysis
10.4.3 Middle East and Africa Anticoagulant Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Anticoagulant Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Anticoagulant Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Anticoagulant Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anticoagulant Market
10.4.6.1.1 South Africa Anticoagulant Market by Drug Class
10.4.6.1.2 South Africa Anticoagulant Market by Route of Administration
10.4.6.1.3 South Africa Anticoagulant Market by Application
10.4.6.2 Saudi Arabia Anticoagulant Market
10.4.6.2.1 Saudi Arabia Anticoagulant Market by Drug Class
10.4.6.2.2 Saudi Arabia Anticoagulant Market by Route of Administration
10.4.6.2.3 Saudi Arabia Anticoagulant Market by Application
10.4.6.3 U.A.E Anticoagulant Market
10.4.6.3.1 U.A.E Anticoagulant Market by Drug Class
10.4.6.3.2 U.A.E Anticoagulant Market by Route of Administration
10.4.6.3.3 U.A.E Anticoagulant Market by Application
10.4.6.4 Rest of Middle East and Africa Anticoagulant Market
10.4.6.4.1 Rest of Middle East and Africa Anticoagulant Market by Drug Class
10.4.6.4.2 Rest of Middle East and Africa Anticoagulant Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Anticoagulant Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anticoagulant Market Overview
10.5.2 South and Central America Anticoagulant Market Forecasts and Analysis
10.5.3 South and Central America Anticoagulant Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Anticoagulant Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Anticoagulant Market Forecasts and Analysis - By Application
10.5.6 South and Central America Anticoagulant Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anticoagulant Market
10.5.6.1.1 Brazil Anticoagulant Market by Drug Class
10.5.6.1.2 Brazil Anticoagulant Market by Route of Administration
10.5.6.1.3 Brazil Anticoagulant Market by Application
10.5.6.2 Argentina Anticoagulant Market
10.5.6.2.1 Argentina Anticoagulant Market by Drug Class
10.5.6.2.2 Argentina Anticoagulant Market by Route of Administration
10.5.6.2.3 Argentina Anticoagulant Market by Application
10.5.6.3 Rest of South and Central America Anticoagulant Market
10.5.6.3.1 Rest of South and Central America Anticoagulant Market by Drug Class
10.5.6.3.2 Rest of South and Central America Anticoagulant Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Anticoagulant Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTICOAGULANT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTICOAGULANT MARKET, KEY COMPANY PROFILES
13.1. ASPEN HOLDINGS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAYER AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BOEHRINGER INGELHEIM GMBH
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BRISTOL-MYERS SQUIBB COMPANY
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DAIICHI SANKYO COMPANY LIMITED
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GLAXOSMITHKLINE PLC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JOHNSON AND JOHNSON
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PORTOLA PHARMACEUTICALS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SANOFI S.A.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. ASPEN HOLDINGS
2. BAYER AG
3. BOEHRINGER INGELHEIM GMBH
4. BRISTOL-MYERS SQUIBB COMPANY
5. DAIICHI SANKYO COMPANY LIMITED
6. GLAXOSMITHKLINE PLC.
7. JOHNSON AND JOHNSON
8. PFIZER, INC.
9. PORTOLA PHARMACEUTICALS, INC.
10. SANOFI S.A.
11. KENRIZ CARE
12. SIGMA-ALDRICH
13. NATCO PHARMA LIMITED
14. ASPEN PHARMACARE
TIPRE00020940
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount